Related Experiment Video
Updated: May 31, 2026

Following in Real Time the Impact of Pneumococcal Virulence Factors in an Acute Mouse Pneumonia Model Using Bioluminescent Bacteria
Published on: February 23, 2014
[Respiratory infections caused by metapneumovirus in elderly patients]
Alberto Fica C1, Loreto Hernández C, Lorena Porte T
1Servicio de Infectología, Departamento de Medicina, Hospital Militar de Santiago, Chile. albertofica@gmail.com
Abstract:
Human metapneumovirus infections are increasingly recognized among adult patients and the aim of this report is to present a series of 4 cases admitted during the winter of 2010. All were detected by direct fluorescence anti-bodies assay of respiratory samples and all were female patients with an age range of 79 to 95 years, including two bedridden cases, one with dementia and three with chronic obstructive pulmonary disease. One patient presented with parainfluenza 3 virus coinfection. Patients presented with pneumonía in 3 cases (interstitial pattern in 2 and lobar consolidation in the other) or acute exacerbation of chronic bronchitis in the remaining case. Symptoms were present for 3 to 7 days before admission and 3 have wheezing. All had hypoxemic or global respiratory failure and lymphopenia (< 1.000/mm³). Hospitalization lasted for 5 to 20 days, marked in the 3 cases that survived by prolonged bronchial obstructive manifestations. Two cases required non invasive mechanical ventilation. Human metapneumovirus infections can decompensate elderly patients with chronic respiratory diseases generating hospital admission and a prolonged morbidity marked by obstructive manifestations and sometimes can become into death.
Insights
Human metapneumovirus infections can severely affect elderly women with chronic lung disease, leading to respiratory failure and prolonged illness. Early detection and management are crucial for these vulnerable patients.
Area of Science:
- Virology
- Geriatric Medicine
- Respiratory Medicine
Context:
- Human metapneumovirus (hMPV) is an emerging respiratory pathogen.
- Increasing recognition of hMPV in adult populations.
- Limited data on hMPV in elderly patients with comorbidities.
Purpose:
- To report a series of four adult cases of human metapneumovirus infection.
- To describe the clinical presentation and outcomes of hMPV in elderly patients.
- To highlight the impact of hMPV on patients with chronic respiratory conditions.
Summary:
- Four elderly female patients (79-95 years) with hMPV infection were admitted in 2010.
- All presented with respiratory failure (pneumonia or COPD exacerbation) and lymphopenia.
- Outcomes included prolonged obstructive symptoms and need for non-invasive ventilation; one case was fatal.
Impact:
- hMPV infections can cause severe illness and decompensation in elderly individuals with chronic respiratory diseases.
- Prolonged morbidity with obstructive manifestations is common post-infection.
- Highlights the importance of considering hMPV in the differential diagnosis of respiratory illness in older adults.
More Related Videos
12:21A Mouse Model for the Transition of Streptococcus pneumoniae from Colonizer to Pathogen upon Viral Co-Infection Recapitulates Age-Exacerbated Illness
Published on: September 28, 2022
04:32Murine Oropharyngeal Aspiration Model of Ventilator-associated and Hospital-acquired Bacterial Pneumonia
Published on: June 28, 2018
Related Concept Videos
Pneumonia I: Introduction
Pneumonia I: Introduction
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
Respiratory Syncytial Virus Disease
Pneumonia V: Nursing management and Prevention
The nurse must practice strict medical asepsis and adhere to infection control guidelines to minimize healthcare-associated infections.
Enhance airway patency
Position the patient correctly to facilitate drainage of the affected lung segments. Manual or mechanical percussion and vibration can also be employed.
Pneumonia II: Pathophysiology
Pneumonia IV: Management
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include: